ID: ALA542178

Max Phase: Preclinical

Molecular Formula: C24H30ClNO6

Molecular Weight: 427.50

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCOc1cc2cc(CO)c(CO)c(-c3cc(N)c(OC)c(OC)c3)c2cc1OCC.Cl

Standard InChI:  InChI=1S/C24H29NO6.ClH/c1-5-30-20-9-14-7-16(12-26)18(13-27)23(17(14)11-21(20)31-6-2)15-8-19(25)24(29-4)22(10-15)28-3;/h7-11,26-27H,5-6,12-13,25H2,1-4H3;1H

Standard InChI Key:  FFPIBIWSDYHXRG-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 427.50

Molecular Weight (Monoisotopic): 427.1995

AlogP: 3.89

#Rotatable Bonds: 9

Polar Surface Area: 103.40

Molecular Species: NEUTRAL

HBA: 7

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 7

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 3.66

CX LogP: 2.33

CX LogD: 2.33

Aromatic Rings: 3

Heavy Atoms: 31

QED Weighted: 0.45

Np Likeness Score: 0.45

References

1. Iwasaki T, Kondo K, Kuroda T, Moritani Y, Yamagata S, Sugiura M, Kikkawa H, Kaminuma O, Ikezawa K..  (1996)  Novel selective PDE IV inhibitors as antiasthmatic agents. Synthesis and biological activities of a series of 1-aryl-2,3-bis(hydroxymethyl)naphthalene lignans.,  39  (14): [PMID:8709099] [10.1021/jm9509096]

Source

Source(1):

• Scientific Literature